Association between duration of gonadotrophin-releasing hormone agonist use and cardiovascular risks: A population-based competing-risk analysis

Chan, JSK; Tang, P; Hui, JMH; Lee, YHA; Dee, EC; Ng, K; Liu, K; Tse, G; Ng, CF

Ng, CF (通讯作者),Chinese Univ Hong Kong, Fac Med, Dept Surg, Div Urol, Hong Kong, Peoples R China.;Tse, G (通讯作者),Tianjin Med Univ, Second Hosp, Tianjin Inst Cardiol, Dept Cardiol,Tianjin Key Lab Ion Mol Funct Cardio, Tianjin 300211, Peoples R China.;Tse, G (通讯作者),Kent & Medway Med Sch, Canterbury CT2 7NT, Kent, England.

PROSTATE, 2022; 82 (15): 1477

Abstract

Background Although androgen deprivation therapy has known cardiovascular risks, it is unclear if its duration is related to cardiovascular risks. Thi......

Full Text Link